Maharashtra FDA — to grant {Chemotherapy drugs} to Mumbai-based {Taj Pharmaceuticals Ltd}

Taj Pharma
2 min readSep 6, 2018

FDA to grant Chemotherapy drugs approval to Taj Pharmaceuticals-chemotherapy for lomustine, everolimus, cyclophosphamide, cisplatin

The Maharashtra FDA to grant regular approval to Mumbai-based {Taj Pharmaceuticals Ltd} Chemotherapy drugs lomustine, everolimus, cyclophosphamide, cisplatin etc. among others with pemetrexed and platinum-based chemotherapy as first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer.

Brain Cancer Treatment

FDA Drug Approvals & Treatment — Cost effective Generics Treatments are available from Mumbai-based Taj Pharmaceuticals Ltd Oncology Division.

Treatment options are limited for recurrent high grade glioma, or HGG.

Current standard of care patients with newly diagnosed glioblastoma, or GBM, includes surgery, radiation therapy and chemotherapy. Approved drug treatments for HGG or GBM include:

Temozolomide is FDA approved for the treatment of GBM, and AA. In patients with newly diagnosed GBM, temozolomide provided a median survival advantage of 2.5 months when added to surgery and radiation therapy. Source: Temodar prescribing information.

FDA granted accelerated approval to bevacizumab for the treatment of recurrent GBM. Thus far, no definitive data have demonstrated that bevacizumab improves disease-related symptoms or survival. Source: Avastin prescribing information.

Lomustine is an anti-cancer chemotherapy that is FDA approved to be used alone or with other drugs to treat recurrent brain cancer. Source: Ceenu prescribing information.

Everolimus is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body. The Afinitor brand of everolimus is used to treat certain types of kidney cancer, breast cancer, or brain tumor.

Tocagen is developing an investigational therapy to treat recurrent HGG, which is under evaluation in an ongoing Phase 3 clinical trial, Toca 5. Learn about the Toca 5 trial.

See additional brain cancer resources below:

Labels: chemotherapy division taj oncology, taj pharmaceutical chemotherapy division, taj oncology chemotherapy companies, cancer drug, Chemotherapy drugs — Taj Pharmaceuticals, taj chemotherapy manufacturer, taj pharmaceutical Chemotherapy, taj pharmaceutical Chemotherapy, news pharmaceutical cancer drug companies, mergers and cancer drug acquisitions, cancer drug development, cancer drug export and import of cancer drugs, cancer drug legislation, cancer drug advertising and influence

--

--

Taj Pharma
Taj Pharma

Written by Taj Pharma

At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry.

No responses yet